4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline(CAS: 99010-64-7)

4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline (CAS: 99010-64-7) must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations for European manufacturers and importers, and FDA/EPA requirements for use and handling in the United States. These guidelines cover storage, transportation, and disposal according to the properties and potential hazards of the compound.

While 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline (CAS: 99010-64-7) is a specific compound, alternatives might include similar imidazoquinoline derivatives such as 4-chloro-1-phenyl-1H-imidazo[4,5-c]quinoline or 4-chloro-1-(2-chlorophenyl)-1H-imidazo[4,5-c]quinoline, which can serve as viable substitutes in various synthetic routes and applications.

There is increasing research interest in 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline (CAS: 99010-64-7) due to its potential as an antiviral and anticancer agent. Market trends show a growing focus on its use in pharmaceuticals and biotechnological applications. Recent studies are exploring its synthetic methods and biological activities.

Waste containing 4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline (CAS: 99010-64-7) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration or other environmental protection methods should be used to ensure the compound is properly managed. Handling should be conducted in a well-ventilated area, and all safety protocols should be followed to prevent environmental contamination and ensure worker safety.